Skip to content

Ozone treatment for Acute Ischemic Stroke within 1 w of Symptom Onset: a A Prospective, Randomized, Multi-center, Open-label, Parallel control, Comparative Study

Ozone treatment for Acute Ischemic Stroke within 1 w of Symptom Onset: a A Prospective, Randomized, Multi-center, Open-label, Parallel control, Comparative Study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-ICR-15007093
Enrollment
Unknown
Registered
2015-09-18
Start date
2015-10-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemic Stroke

Interventions

Sponsors

The General Hospital of Shenyang Military
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria 1. aged 18-80 years; 2. the incidence of 1 week; 3. NIHSS score 4-20 points were; 4. blood pressure <180/110mmHg; 5. head CT imaging changes without bleeding; 6. the first onset or should not be left in the past incidence of limb paralysis andother sequelae onset again, this does not affect the NIHSS score, previous onset of this admission mRS score =1 points. 7. signed informed consent.

Exclusion criteria

Exclusion criteria: Exclusion criteria (1) pregnant or lactating women; (2) before starting treatment of symptoms has rapidly improved; (3) mixed hemorrhagic stroke or stroke; (4) severe cerebral edema, or coma condition unstable persons; (5) After examination confirmed by a brain tumor patients with stroke, traumatic brain injury, blood diseases caused; (6) due to rheumatic heart disease, coronary heart disease andother heart disease atrial fibrillation caused by cerebral embolism; (7) with severe infection or liver, kidney, hematopoietic system, the endocrine system andother serious diseases andbone andjoint ill; (8) a history of stroke andleft severe sequelae; (9) for the treatment andrehabilitation of patients andtheir families a negative attitude, not actively cooperate with the person; (10) by combining the following diseases: bean disease (glucose 6-phosphate dehydrogenase deficiency), hyperthyroidism, sickle-cell anemia; (11) The researchers believe that the other person is not suitable to participate in this trial.

Design outcomes

Primary

MeasureTime frame
90 days mRS score;

Countries

China

Contacts

Public ContactHuisheng Chen
chszh@aliyun.com+86 13352452086

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 2, 2026